Stock Opinions by David King - Stockchase Experts
WATCH LIST
4
David King

On Stockchase since : Apr 2004

Portfolio Manager, New Value Fund at Putnam Investments

Reveal Expert Performance

David King hasn’t left any messages.


David King Latest Top Picks...

Stock Opinions by David King - Stockchase Experts

Signal Opinion Expert Chart
TOP PICK
Fannie Mae(FNMA-OTC) 

April 30, 2004

A pure value buy. 9 X trailing PE and 3% yield is intriguing. Headline risk is not as important as were the numbers and up ultimately.
Financial Services
0 0 0 0 0
0 comments
A pure value buy. 9 X trailing PE and 3% yield is intriguing. Headline risk is not as important as were the numbers and up ultimately.
Financial Services
0 0 0 0 0
0 comments
David King

Portfolio , Putnam Investments...

Price Price
$68.710
Owned Owned
Yes

Sign up or Log in to enjoy full view of charts.

TOP PICK
Xerox(XRX-N) 

April 30, 2004

Betting on the franchise. Benefits from economic recovery on a global basis. Exciting product line with their iGen3. Still cheap.
misc industrial products
0 0 0 0 0
0 comments
Betting on the franchise. Benefits from economic recovery on a global basis. Exciting product line with their iGen3. Still cheap.
misc industrial products
0 0 0 0 0
0 comments
David King

Portfolio , Putnam Investments...

Price Price
$13.430
Owned Owned
Yes

Sign up or Log in to enjoy full view of charts.

BUY
Abbott Labs(ABT-N) 

April 30, 2004

Attractive. Continuing turnaround in their diagnostic business as well as a better pipeline than some of the other chief pharmaceuticals.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Attractive. Continuing turnaround in their diagnostic business as well as a better pipeline than some of the other chief pharmaceuticals.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David King

Portfolio , Putnam Investments...

Price Price
$44.020
Owned Owned
Unknown

Sign up or Log in to enjoy full view of charts.

BUY
A potential takeover play. Has been a bit undermanaged and is very cheap.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A potential takeover play. Has been a bit undermanaged and is very cheap.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David King

Portfolio , Putnam Investments...

Price Price
$17.250
Owned Owned
Unknown

Sign up or Log in to enjoy full view of charts.

Showing 1 to 4 of 4 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days